这个不是实验失败了吗_老虎社区_美港股上老虎 - 老虎社区

点赞
1
收藏

美股收割者
2020-04-29

这个不是实验失败了吗。还发出来了。怎么又可以了。

吉利德科学的瑞德西韦新冠临床试验已达到主要评估指标

4月29日讯，吉利德科学盘前停牌，吉利德科学的瑞德西韦新冠临床试验已达到主要评估指标。吉利德科学在德股价涨10%。吉利德科学：第二次简单试验的前600名患者的结果预计在5月底出炉。接受10天瑞德西韦治

吉利德科学的瑞德西韦新冠临床试验已达到主要评估指标

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

点赞

举报

评论（1）

推荐
最新

d2018
·2020-04-29
因为不允许他有效，姓资
回复
点赞
举报

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":924095211,"tweetId":"924095211","gmtCreate":1588163937133,"gmtModify":1704366672659,"author":{"id":3460666790917626,"idStr":"3460666790917626","authorId":3460666790917626,"authorIdStr":"3460666790917626","name":"美股收割者","avatar":"https://static.tigerbbs.com/23963645b645bd21e93e660db778257a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>这个不是实验失败了吗。还发出来了。怎么又可以了。</p></body></html>","htmlText":"<html><head></head><body><p>这个不是实验失败了吗。还发出来了。怎么又可以了。</p></body></html>","text":"这个不是实验失败了吗。还发出来了。怎么又可以了。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/924095211","repostId":1108976612,"repostType":4,"repost":{"id":"1108976612","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1588163821,"share":"https://www.laohu8.com/m/news/1108976612?lang=&edition=full","pubTime":"2020-04-29 20:37","market":"us","language":"zh","title":"吉利德科学的瑞德西韦新冠临床试验已达到主要评估指标","url":"https://stock-news.laohu8.com/highlight/detail?id=1108976612","media":"老虎资讯综合","summary":"4月29日讯，吉利德科学盘前停牌，吉利德科学的瑞德西韦新冠临床试验已达到主要评估指标。吉利德科学在德股价涨10%。吉利德科学：第二次简单试验的前600名患者的结果预计在5月底出炉。接受10天瑞德西韦治","content":"<p><span>4月29日讯，<a href=\"https://laohu8.com/S/GILD\">吉利德科学</a>盘前停牌，</span>吉利德科学的瑞德西韦新冠临床试验已达到主要评估指标。<span>吉利德科学在德股价涨10%。</span></p><p><span>吉利德科学：第二次简单试验的前600名患者的结果预计在5月底出炉。接受10天瑞德西韦治疗的患者与接受5天治疗的患者的临床状态出现了相似的改善。在意大利以外的地区，在研究的第14天，两个治疗组（5天和10天治疗组）的整体死亡率为7%。</span></p><p><img src=\"https://static.tigerbbs.com/dee6cfb37e279131634eba2667eca5b1\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>吉利德科学的瑞德西韦新冠临床试验已达到主要评估指标</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n吉利德科学的瑞德西韦新冠临床试验已达到主要评估指标\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-04-29 20:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><span>4月29日讯，<a href=\"https://laohu8.com/S/GILD\">吉利德科学</a>盘前停牌，</span>吉利德科学的瑞德西韦新冠临床试验已达到主要评估指标。<span>吉利德科学在德股价涨10%。</span></p><p><span>吉利德科学：第二次简单试验的前600名患者的结果预计在5月底出炉。接受10天瑞德西韦治疗的患者与接受5天治疗的患者的临床状态出现了相似的改善。在意大利以外的地区，在研究的第14天，两个治疗组（5天和10天治疗组）的整体死亡率为7%。</span></p><p><img src=\"https://static.tigerbbs.com/dee6cfb37e279131634eba2667eca5b1\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","relate_stocks":{"GILD":"吉利德科学"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108976612","content_text":"4月29日讯，吉利德科学盘前停牌，吉利德科学的瑞德西韦新冠临床试验已达到主要评估指标。吉利德科学在德股价涨10%。吉利德科学：第二次简单试验的前600名患者的结果预计在5月底出炉。接受10天瑞德西韦治疗的患者与接受5天治疗的患者的临床状态出现了相似的改善。在意大利以外的地区，在研究的第14天，两个治疗组（5天和10天治疗组）的整体死亡率为7%。","news_type":1},"isVote":1,"tweetType":1,"viewCount":2092,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":45,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":2392601,"commentId":"2392601","gmtCreate":1588164312060,"gmtModify":1588164312060,"authorId":3496907010867794,"author":{"id":3496907010867794,"idStr":"3496907010867794","authorId":3496907010867794,"name":"d2018","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":924095211,"objectIdStr":"924095211","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"因为不允许他有效，姓资","text":"因为不允许他有效，姓资","html":"因为不允许他有效，姓资","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}